The Scientist

» TLR3 and culture

Most Recent

image: Speaking of Science 2015

Speaking of Science 2015

By | December 31, 2015

A year’s worth of noteworthy quotes

0 Comments

image: Capsule Reviews

Capsule Reviews

By | December 1, 2015

A year’s worth of noteworthy quotes

0 Comments

image: Self Correction

Self Correction

By | December 1, 2015

A year’s worth of noteworthy quotes

0 Comments

image: Agar Shortage Limits Lab Supplies

Agar Shortage Limits Lab Supplies

By | November 24, 2015

A year’s worth of noteworthy quotes

1 Comment

image: Following the Funding

Following the Funding

By | November 4, 2015

A year’s worth of noteworthy quotes

0 Comments

image: Capsule Reviews

Capsule Reviews

By | November 1, 2015

A year’s worth of noteworthy quotes

0 Comments

image: 2015 Life Sciences Salary Survey

2015 Life Sciences Salary Survey

By and | November 1, 2015

A year’s worth of noteworthy quotes

13 Comments

image: Scientists Skip Cell Line Validation

Scientists Skip Cell Line Validation

By | October 12, 2015

A year’s worth of noteworthy quotes

2 Comments

image: Debating the Value of Anonymity

Debating the Value of Anonymity

By | October 5, 2015

A year’s worth of noteworthy quotes

1 Comment

image: Ready, Willing, and Able

Ready, Willing, and Able

By | October 1, 2015

A year’s worth of noteworthy quotes

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech